Navigation Links
Consumer Reports Finds Filter-Based Air Purifiers are Better Choice for Consumers
Date:11/5/2007

oving smoke --- an issue if there are people living in the house who smoke.

"There is little definitive medical evidence that using an air cleaner will help people's allergies and asthma," said Celia Kuperszmid Lehrman, deputy home editor for Consumer Reports. "If you don't have asthma or aren't allergic to pet allergens and dust, and keep your house reasonably clean, you probably don't need an air purifier."

Lehrman also pointed out that many of the germ-cleaning claims of air purifiers--which are supposed to rid your home of airborne bacteria in addition to dust, pollen and smoke--are oversold: While CR's tests of five portable air purifiers that made those claims confirmed that they reduce germs in the air, so should any purifier that effectively removes dust and smoke.

Full tests and ratings of air purifiers appear in the December issue of Consumer Reports, on sale now. The complete report is also available to subscribers at http://www.ConsumerReports.org.

Not Acceptable: Two Ozone Generators

Ozone generators, another type of purifier, are a growing part of the market. They create large amounts of ozone by design and claim to use it to purify the air.

Consumer Reports rated two such models --- the $850 EcoQuest Fresh Air and the $230 EdenPure Area --- Not Acceptable because even at the generators' low everyday settings, their ozone production quickly exceeded the 50 parts per billion limit (ppb) set by the U.S. Food and Drug Administration for medical devices. Purifiers aren't considered medical devices by the FDA. Ozone concentrations in CR's test room measured about 650 to 990 ppb for the EdenPure, depending on the setting. The EcoQuest produced about 110 to 350 ppb at its normal and high settings, and up to 4,300 ppb at its "away" settings, which the company says to use only when you and your pets aren't home.

California recently banned the sale of ozon
'/>"/>

SOURCE Consumer Reports
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Consumers Offer to Pay More to Satisfy Health Demands
2. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Naked Juice Brings Consumers Happiness by the Billions With First 100% Juice Smoothie Containing Probiotics
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. Hospitals Agree to Pay Fees in Exchange for More Income, but Consumers in the Dark About What Theyll be Charged Under Nunez Plan
7. PA Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Perry County Dairy
8. Injuries, Deaths Tied to Consumer Drugs Rise Sharply
9. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
10. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
11. PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... ORLEANS, Dec. 5 There have been significant scientific ... experts continue to gain a better understanding of how ... options and provide patients with the best care. Research ... American Society of Hematology explores optimal induction therapies for ...
(Date:12/5/2009)... Dec. 5 Leukemia and myeloproliferative disorders are ... today at the 51st Annual Meeting of the ... options and improved diagnostic methods for patients suffering ... acute lymphoblastic leukemia, and myelofibrosis that are based ...
(Date:12/5/2009)... International Solutions, an innovative new international private medical insurance plan which ... to offering customers the flexibility to add or remove a wide ... enables customers to tailor their benefits to complement those already offered ... ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ("Care" ... declared a dividend of $0.17 per share of common stock. ... of record on December 14, 2009. ,, ... a real estate investment and finance company investing in healthcare-related real ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 The American Association of Homes and ... that the Community Living and Supportive Services (CLASS) provisions ... provisions are essential for providing support to elders, people with ... to pass a health care reform bill that will make ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... at Washington University has highlighted a new combination drug ... modality claims to even restore normal breathing in affected ... have revealed promising findings, the results of which can ... dual drug combination is believed to enhance airway function ...
... Institute of General Medical Sciences, one of the National ... award of national Models of Infectious Disease Agent Study ... and Harvard Pilgrim Health Care-led research team. ... powerful mathematical and statistical modeling techniques. These techniques would ...
... every possibility that there could be a common gene which ... the // Indiana University School of Medicine. This could also ... Genetic information is sought from about 1,000 families in which ... ,The genetic link with regard to the ...
... Weizmann Institute of Science’s researchers have discovered ancient DNA ... Proceedings of the National Academy of Sciences// (PNAS) has ... provides information with regard to population dynamics, evolution, diets ... and animals. ,Contaminated DNA may also ...
... University of Arizona has reported in the Journal Osteoporosis ... regular exercise makes their bone fit and prevents bone ... highly reduces the risk of developing Osteoporosis in older ... age people and is more prominent in women than ...
... RotaTeq for rotavirus has been approved by the US. The ... lives of about 500,000 children across the world annually. // ... the medicine's maker tested the vaccine on more than 70,000 ... ,Rotavirus is a highly contagious virus that causes severe ...
Other Medicine News:Health News:Detecting Epidemics using statistics 2
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... chemical threats, announced today that the Company is ... of Valortim® in an inhalation anthrax model in ... data are being presented during an oral session ...
(Date:12/4/2009)... HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced the ... by PennWell Corporation , a leader in ... dentistry. The course focuses on patient views ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented results ... of secondary end points of biochemical recurrence rate in ... for injection) or monthly leuprolide in prostate cancer patients ... patients who received FIRMAGON 240/80 mg/month had a recurrence ...
Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Mingling Martinis 26amp 3B Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 59087 1Mingling Martinis 26amp 3B Mysterious Murder Masquerade at the Whitney to Benefit Carnival of Care 59087 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 1BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 3Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 1Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 2
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
For the qualitative detection of antibodies to Treponema pallidum in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... Pacemaker Follow-Up Solution makes convenience and ... our Cardiac Monitoring Center, qualified professionals ... seven days a week for Pacemaker ... time they experience a problem or ...
Medicine Products: